Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-023492
Filing Date
2025-08-13
Accepted
2025-08-13 16:16:36
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1093625
2 EX-31.1 ex31-1.htm EX-31.1 19211
3 EX-31.2 ex31-2.htm EX-31.2 19537
4 EX-32.1 ex32-1.htm EX-32.1 7681
5 EX-32.2 ex32-2.htm EX-32.2 7696
6 GRAPHIC form10-q_001.jpg GRAPHIC 19573
  Complete submission text file 0001641172-25-023492.txt   6594615

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE dyai-20250630.xsd EX-101.SCH 40817
8 XBRL CALCULATION FILE dyai-20250630_cal.xml EX-101.CAL 51233
9 XBRL DEFINITION FILE dyai-20250630_def.xml EX-101.DEF 239207
10 XBRL LABEL FILE dyai-20250630_lab.xml EX-101.LAB 430107
11 XBRL PRESENTATION FILE dyai-20250630_pre.xml EX-101.PRE 343358
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1079519
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 251211878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)